The Foundation for Stroke Prevention
  • Home
  • Blog
  • Risk Factors
  • Warning Signs
  • Diagnostic Tests
  • About Us
Select Page

Major Study Establishes Safety of New Stroke Drug

by Steven Rudolph | Nov 2, 2022 | Uncategorized | 0 comments

In 1996, Alteplase, a clot dissolving drug also known as tPA became the first available treatment for the most common type of stroke. It revolutionized the treatment of stroke around the world.

https://www.ucalgary.ca/news/ucalgary-researchers-calgary-stroke-program-make-another-breakthrough-treatment-stroke

Tweet

Recent Posts

  • 10 Minutes of walking a day may extend life in octogenarians
  • Major Study Establishes Safety of New Stroke Drug
  • Strokes in the Eye May be a Warning of Future Brain Strokes
  • USPSTF Recommends Against Routine Carotid Screening
  • FDA approves new fish-oil medication for stroke prevention

The Foundation for Stroke Prevention

About Us

Blog

Resources for Professionals

Contact

Copyright © 2022
The Foundation for Stroke Prevention